- Home
- FORA vs IOBT Comparison
FORA vs IOBT Comparison
Compare FORA & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORA
- IOBT
- Stock Information
- Founded
- FORA 2014
- IOBT 2014
- Country
- FORA United States
- IOBT Denmark
- Employees
- FORA N/A
- IOBT N/A
- Industry
- FORA Computer Software: Prepackaged Software
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- FORA Technology
- IOBT Health Care
- Exchange
- FORA Nasdaq
- IOBT Nasdaq
- Market Cap
- FORA 63.8M
- IOBT 56.7M
- IPO Year
- FORA N/A
- IOBT 2021
- Fundamental
- Price
- FORA $2.01
- IOBT $0.77
- Analyst Decision
- FORA Strong Buy
- IOBT Strong Buy
- Analyst Count
- FORA 1
- IOBT 3
- Target Price
- FORA $5.00
- IOBT $9.33
- AVG Volume (30 Days)
- FORA 17.1K
- IOBT 629.7K
- Earning Date
- FORA 11-13-2024
- IOBT 11-12-2024
- Dividend Yield
- FORA N/A
- IOBT N/A
- EPS Growth
- FORA N/A
- IOBT N/A
- EPS
- FORA N/A
- IOBT N/A
- Revenue
- FORA $19,709,723.00
- IOBT N/A
- Revenue This Year
- FORA N/A
- IOBT N/A
- Revenue Next Year
- FORA $13.59
- IOBT N/A
- P/E Ratio
- FORA N/A
- IOBT N/A
- Revenue Growth
- FORA N/A
- IOBT N/A
- 52 Week Low
- FORA $1.97
- IOBT $0.66
- 52 Week High
- FORA $4.15
- IOBT $2.10
- Technical
- Relative Strength Index (RSI)
- FORA 48.22
- IOBT 39.04
- Support Level
- FORA $1.99
- IOBT $0.75
- Resistance Level
- FORA $2.05
- IOBT $0.84
- Average True Range (ATR)
- FORA 0.05
- IOBT 0.07
- MACD
- FORA -0.00
- IOBT 0.00
- Stochastic Oscillator
- FORA 41.18
- IOBT 13.79
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.